Tourette Syndrome News and Research

Latest Tourette Syndrome News and Research

Deutetrabenazine may help improve chorea symptoms in patients with HD

People with Huntington disease (HD) experienced improvements in chorea while taking deutetrabenazine (SD-809) compared to placebo, according to a paper published today in the Journal of the American Medical Association.

6 Jul 2016

New deep brain stimulation improves symptoms in Tourette's patients

Specifically-targeted deep brain stimulation improves symptoms in patients with severe Tourette's, a study reports in the current issue of Biological Psychiatry.

4 Mar 2016

Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Neurocrine Biosciences, Inc. today announced its financial results for the quarter and year ended December 31, 2015.

12 Feb 2016

Neurocrine Biosciences announces positive data from NBI-98854 Phase III trial in tardive dyskinesia

Neurocrine Biosciences, Inc. announced today that NBI-98854, a highly selective small molecule VMAT2 inhibitor, showed a statistically significant reduction in tardive dyskinesia during the six weeks of placebo-controlled treatment in the Kinect 3 clinical trial. This Phase III trial included moderate to severe tardive dyskinesia patients with underlying schizophrenia, schizoaffective disorder, bipolar or major depressive disorder.

8 Oct 2015

Neurocrine completes enrollment in Phase III clinical trial of NBI-98854 in tardive dyskinesia patients

Neurocrine Biosciences, Inc. announced today that it has recently completed subject randomization of the Phase III clinical trial (Kinect 3 Study) of its proprietary Vesicular Mono-Amine Transporter 2 (VMAT2) compound NBI-98854 in tardive dyskinesia patients.

13 Aug 2015

First self-assessment test developed to help clinicians diagnose autism in adults

Psychologists from Cardiff University have developed the first self-assessment test designed to help clinicians diagnose autism in adults.

7 Aug 2015

Cognitive behavioural therapy can change brain function of people with Tourette syndrome

In addition to its effect on chronic tics, cognitive behavioural therapy (CBT) can change the brain function of people with Tourette syndrome.

25 Jun 2015

Neurocrine reports net loss of $1.2 million for first quarter 2015

Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended March 31, 2015. For the first quarter of 2015, the Company reported a net loss of $1.2 million, or $0.01 loss per share, compared to a net loss of $11.8 million, or $0.17 loss per share, for the same period in 2014.

30 Apr 2015

Tourette syndrome patients may face second psychiatric disorder during their lifetimes

A new study of Tourette syndrome (TS) led by researchers from UC San Francisco and Massachusetts General Hospital has found that nearly 86 percent of patients who seek treatment for TS will be diagnosed with a second psychiatric disorder during their lifetimes, and that nearly 58 percent will receive two or more such diagnoses.

10 Mar 2015

Declarative memory helps individuals with neurodevelopmental disorders compensate for dysfunction

Individuals with five neurodevelopmental disorders -- autism spectrum disorder, obsessive-compulsive disorder, Tourette syndrome, dyslexia, and Specific Language Impairment -- appear to compensate for dysfunction by relying on a single powerful and nimble system in the brain known as declarative memory.

13 Feb 2015

AAN urges for more research on use of medical marijuana for brain, nervous system disorders

The American Academy of Neurology is calling for more research on the use of medical marijuana for brain, spine and nervous system disorders in a new position statement released by the AAN, the world's largest association of neurologists with more than 28,000 members.

18 Dec 2014

Neurocrine Biosciences' NBI-98854 drug gets breakthrough designation for tardive dyskinesia

Neurocrine Biosciences, Inc. announced today that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for its Vesicular Monoamine Transporter 2 inhibitor, NBI-98854, in tardive dyskinesia.

30 Oct 2014

Teen binge drinking effects may last a lifetime, suggests UMass Amherst study

Binge drinking can have lasting effects on brain pathways that are still developing during adolescence, say neuroscience researcher Heather N. Richardson and her colleagues at the University of Massachusetts Amherst and Louisiana State University.

29 Oct 2014

Intensive parenting and education provided in homes reduces drug use in pregnant teens

Intensive parenting and health education provided in homes of pregnant American Indian teens reduced the mothers' illegal drug use, depression and behavior problems, and set their young children on track to meet behavioral and emotional milestones they may have otherwise missed.

13 Oct 2014

Identification of neurotransmitter imbalance in Tourette Syndrome offers new treatment hope

Recent research, published yesterday, has identified a chemical transmitter in the brain that plays a vital role in Tourette Syndrome. This latest finding presents the potential for developing targeted, and therefore more effective, treatments to suppress the distressing symptoms of Tourette Syndrome.

26 Sep 2014

Scientists develop algorithm to uncover genomic insertions and deletions involved in autism, OCD

With three billion letters in the human genome, it seems hard to believe that adding a DNA base here or removing a DNA base there could have much of an effect on our health.

18 Aug 2014

AAN review finds certain forms of medical marijuana can help treat some symptoms of MS

A review by the American Academy of Neurology of available scientific research on the use of medical marijuana in brain diseases finds certain forms of medical marijuana can help treat some symptoms of multiple sclerosis (MS), but do not appear to be helpful in treating drug-induced (levodopa) movements in Parkinson's disease.

29 Apr 2014

Children with Tourette syndrome may unconsciously train brain to effectively control tics

Children with Tourette Syndrome (TS) may unconsciously train their brain to more effectively control their tics.

17 Apr 2014

Study raises hopes for new drugs to treat brain disorders associated with neurotransmitter imbalance

Although drugs have been developed that inhibit the imbalance of neurotransmitters in the brain - a condition which causes many brain disorders and nervous system diseases - the exact understanding of the mechanism by which these drugs work has not yet been fully understood.

8 Jan 2014

Chinese herbal medicine effective at alleviating acute inflammatory and nerve pain

A compound derived from a traditional Chinese herbal medicine has been found effective at alleviating pain, pointing the way to a new nonaddictive analgesic for acute inflammatory and nerve pain, according to UC Irvine pharmacology researchers.

3 Jan 2014

Tourette Syndrome News and Research

Latest Tourette Syndrome News and Research

Deutetrabenazine may help improve chorea symptoms in patients with HD

New deep brain stimulation improves symptoms in Tourette's patients

Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Neurocrine Biosciences announces positive data from NBI-98854 Phase III trial in tardive dyskinesia

Neurocrine completes enrollment in Phase III clinical trial of NBI-98854 in tardive dyskinesia patients

First self-assessment test developed to help clinicians diagnose autism in adults

Cognitive behavioural therapy can change brain function of people with Tourette syndrome

Neurocrine reports net loss of $1.2 million for first quarter 2015

Tourette syndrome patients may face second psychiatric disorder during their lifetimes

Declarative memory helps individuals with neurodevelopmental disorders compensate for dysfunction

AAN urges for more research on use of medical marijuana for brain, nervous system disorders

Neurocrine Biosciences' NBI-98854 drug gets breakthrough designation for tardive dyskinesia

Teen binge drinking effects may last a lifetime, suggests UMass Amherst study

Intensive parenting and education provided in homes reduces drug use in pregnant teens

Identification of neurotransmitter imbalance in Tourette Syndrome offers new treatment hope

Scientists develop algorithm to uncover genomic insertions and deletions involved in autism, OCD

AAN review finds certain forms of medical marijuana can help treat some symptoms of MS

Children with Tourette syndrome may unconsciously train brain to effectively control tics

Study raises hopes for new drugs to treat brain disorders associated with neurotransmitter imbalance

Chinese herbal medicine effective at alleviating acute inflammatory and nerve pain

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Tourette Syndrome News and Research

Latest Tourette Syndrome News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in